Drug Shortage Report for TESTOSTERONE ENANTHATE INJECTION, USP
| Report ID | 255771 |
| Drug Identification Number | 02536315 |
| Brand name | TESTOSTERONE ENANTHATE INJECTION, USP |
| Common or Proper name | TESTOSTERONE ENANTHATE INJECTION, USP |
| Company Name | HIKMA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | TESTOSTERONE ENANTHATE |
| Strength(s) | 200MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 5mL |
| ATC code | G03BA |
| ATC description | ANDROGENS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2025-04-25 |
| Estimated end date | 2025-06-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-04-26 |
| Company comments | Inventory available on allocation at distributors. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2025-04-26 | English | Compare |
| v2 | 2025-04-25 | French | Compare |
| v1 | 2025-04-25 | English | Compare |
Showing 1 to 3 of 3